MedPath

Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer

Early Phase 1
Completed
Conditions
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
FIGO Grade 3 Endometrial Endometrioid Adenocarcinoma
FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
Interventions
Procedure: Hysterectomy
Other: Laboratory Biomarker Analysis
Registration Number
NCT03018249
Lead Sponsor
National Cancer Institute (NCI)
Brief Summary

This randomized surgical window trial evaluates the effect of adding entinostat to medroxyprogesterone acetate before surgery works on progesterone receptors on endometrioid endometrial tumors. Medroxyprogesterone acetate is a progesterone, a hormone produced by body normally. Entinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving medroxyprogesterone acetate with or without entinostat may effect tumors from endometrioid endometrial cancer.

Detailed Description

PRIMARY OBJECTIVES:

I. To determine whether the addition of the histone deacetylase inhibitor, entinostat, in combination with medroxyprogesterone acetate in the pre-operative setting results in up-regulation of activated progesterone receptors (PR) compared to medroxyprogesterone acetate alone.

SECONDARY OBJECTIVES:

I. To assess the response rate (as measured by cellular morphology and proliferation) and change in activated receptor levels with the addition of entinostat at the time of hysterectomy.

OUTLINE: Two arms were randomly allocated to eligible patients with equal probability.

ARM I: Patients receive medroxyprogesterone acetate intramuscularly (IM) on day 1 and undergo hysterectomy between days 21-24.

ARM II: Patients receive medroxyprogesterone acetate IM on day 1 and entinostat orally (PO) on days 1, 8, and 15. Patients undergo hysterectomy between days 21-24.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • Patients must have a histologically proven diagnosis of endometrioid endometrial adenocarcinoma by endometrial curettage or biopsy within 8 weeks prior to registration; central pathology review will be required as part of the study but not for registration purposes
  • History/physical examination within 42 +/- 5 days of planned surgical procedure (18-21 days from day 1); further protocol-specific assessments
  • The trial is open only to women with primary endometrioid adenocarcinoma of the uterine corpus (all histologic grades and stages) who are planned and appropriate for primary surgical treatment to include removal of the uterine corpus via any surgical modality; the patient must be considered a suitable surgical candidate
  • Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, 2, or 3 within 28 days prior to registration
  • Formalin-fixed, paraffin-embedded tumor tissue from the biopsy or curettage must be submitted along with the corresponding pathology report
  • Platelets >= 100,000/ul
  • Granulocytes (ANC) >= 1,500/ul
  • Creatinine =< 1.6 mg/dl
  • Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< 3 x upper limits of normal
  • Bilirubin within institutional normal limits
  • The patient must provide study-specific informed consent and authorization permitting release of personal health information prior to study entry
  • Any patients of childbearing potential must have a negative pregnancy test
Exclusion Criteria
  • Patients with any non-endometrioid histology (such as serous, clear cell, or carcinosarcoma)
  • Patients who have received prior progestin or anti-estrogen therapy during the 3 months before the diagnosis of endometrioid adenocarcinoma of the uterine corpus is established; estrogen therapy alone is allowed
  • Patients with ECOG performance grade of 4
  • Patients with history of thrombophlebitis within the past 2 years or ongoing thromboembolic disorders
  • Patients who have previously received systemic, radiation or other treatment for uterine cancer
  • Patients for whom formalin-fixed, paraffin-embedded tumor tissue from the biopsy or curettage is unavailable
  • Patients must not have previously received a non Food and Drug Administration (FDA) approved histone deacetylase (HDAC) inhibitor in a clinical trial setting (entinostat, belinostat)
  • Patients must not be currently taking or have ever taken vorinostat (Zolinza, Merck), panobinostat (Farydak, Novartis) or romidepsin (Istodax, Gloucester Pharmaceuticals)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm II (medroxyprogesterone acetate, entinostat, hysterectomy)HysterectomyPatients receive medroxyprogesterone acetate IM on day 1 and entinostat PO on days 1, 8, and 15. Patients undergo hysterectomy between days 21-24.
Arm II (medroxyprogesterone acetate, entinostat, hysterectomy)Laboratory Biomarker AnalysisPatients receive medroxyprogesterone acetate IM on day 1 and entinostat PO on days 1, 8, and 15. Patients undergo hysterectomy between days 21-24.
Arm I (medroxyprogesterone acetate, hysterectomy)HysterectomyPatients receive medroxyprogesterone acetate IM on day 1 and undergo hysterectomy between days 21-24.
Arm I (medroxyprogesterone acetate, hysterectomy)Laboratory Biomarker AnalysisPatients receive medroxyprogesterone acetate IM on day 1 and undergo hysterectomy between days 21-24.
Arm I (medroxyprogesterone acetate, hysterectomy)Medroxyprogesterone AcetatePatients receive medroxyprogesterone acetate IM on day 1 and undergo hysterectomy between days 21-24.
Arm II (medroxyprogesterone acetate, entinostat, hysterectomy)EntinostatPatients receive medroxyprogesterone acetate IM on day 1 and entinostat PO on days 1, 8, and 15. Patients undergo hysterectomy between days 21-24.
Arm II (medroxyprogesterone acetate, entinostat, hysterectomy)Medroxyprogesterone AcetatePatients receive medroxyprogesterone acetate IM on day 1 and entinostat PO on days 1, 8, and 15. Patients undergo hysterectomy between days 21-24.
Primary Outcome Measures
NameTimeMethod
Mean Post-treatment Tumor Progesterone Receptor H-score (Histology Score)Specimens were collected at hysterectomy on day 21-24 and analyzed in batch.

The H-score is defined as the percent cells staining positive (0-100) multiplied by the staining intensity (0, 1, 2 or 3) measured in the tumor by immunohistochemistry and averaged over 3 reviewers. This score can range from 0 to 300. In general, PRs are expected to decrease in response to medroxyprogesterone acetate. It was hypothesized that entinostat would mitigate the decrease in PR relative to the medroxyprogesterone acetate only arm post treatment. Higher PR H-scores post treatment in the arm with entinostat relative to the medroxyprogesterone alone arm would be consistent with this hypothesis. Arm II was thought to result in higher scores which was expected to have a more favorable outcome when treated with MPA therapy.

Secondary Outcome Measures
NameTimeMethod
Percent of Participants With a Ki67 ResponseSpecimens were collected at initial diagnostic biopsy and at hysterectomy on day 21-24 and analyzed in batch.

A response was defined as a decrease in Ki-67 protein expression in tumor from pre- to post-treatment.

Percentage of Participants With a Histologic ResponseSpecimens were collected at initial diagnostic biopsy and at hysterectomy on day 21-24 and analyzed in batch.

Pre- and post-treatment slides for each patient were evaluated in pairs for complete or partial histologic response by one reviewer. Pre- and post-treatment slides for each patient were evaluated in pairs for complete or partial histologic response by one reviewer. A histologic response was defined as either the absence of identifiable adenocarcinoma in the hysterectomy specimen section (complete) or, subjectively, as the presence of a complex proliferation of glands that retain the architectural characteristics of adenocarcinoma, but with features of secretion, decreased nuclear stratification, or the presence of eosinophilic, squamous or mucinous metaplasia, when this was absent in the initial sample (partial).

The Frequency and Severity of CTCAE Version 4.0 Graded Adverse Events (AE)Up to 45 days after surgery

Maximum grade of physician assessed adverse events reported during treatment and up to 45 days after surgery. Grades start with 1 which is considered mild through grade 5 which is death. Participants on this study had adverse event grades up to grade 3 which is considered moderately severe.

Trial Locations

Locations (234)

The Mark H Zangmeister Center

🇺🇸

Columbus, Ohio, United States

UPMC-Saint Clair Hospital Cancer Center

🇺🇸

Pittsburgh, Pennsylvania, United States

John Muir Medical Center-Concord Campus

🇺🇸

Concord, California, United States

Penrose-Saint Francis Healthcare

🇺🇸

Colorado Springs, Colorado, United States

Boulder Community Hospital

🇺🇸

Boulder, Colorado, United States

Rocky Mountain Cancer Centers-Boulder

🇺🇸

Boulder, Colorado, United States

Southwest Oncology PC

🇺🇸

Durango, Colorado, United States

University of New Mexico Cancer Center

🇺🇸

Albuquerque, New Mexico, United States

Roswell Park Cancer Institute

🇺🇸

Buffalo, New York, United States

Genesis Healthcare System Cancer Care Center

🇺🇸

Zanesville, Ohio, United States

Newark Radiation Oncology

🇺🇸

Newark, Ohio, United States

Kalispell Regional Medical Center

🇺🇸

Kalispell, Montana, United States

Dartmouth Hitchcock Medical Center

🇺🇸

Lebanon, New Hampshire, United States

UPMC Cancer Centers - Arnold Palmer Pavilion

🇺🇸

Greensburg, Pennsylvania, United States

Ohio State University Comprehensive Cancer Center

🇺🇸

Columbus, Ohio, United States

Riverside Methodist Hospital

🇺🇸

Columbus, Ohio, United States

Doctors Hospital

🇺🇸

Columbus, Ohio, United States

Strecker Cancer Center-Belpre

🇺🇸

Belpre, Ohio, United States

Billings Clinic Cancer Center

🇺🇸

Billings, Montana, United States

Grady Memorial Hospital

🇺🇸

Delaware, Ohio, United States

Marietta Memorial Hospital

🇺🇸

Marietta, Ohio, United States

Mount Carmel East Hospital

🇺🇸

Columbus, Ohio, United States

Columbus Oncology and Hematology Associates Inc

🇺🇸

Columbus, Ohio, United States

Women's Cancer Care Associates LLC

🇺🇸

Albany, New York, United States

Adena Regional Medical Center

🇺🇸

Chillicothe, Ohio, United States

UPMC-Magee Womens Hospital

🇺🇸

Pittsburgh, Pennsylvania, United States

Delaware Health Center-Grady Cancer Center

🇺🇸

Delaware, Ohio, United States

Fairfield Medical Center

🇺🇸

Lancaster, Ohio, United States

UPMC-Heritage Valley Health System Beaver

🇺🇸

Beaver, Pennsylvania, United States

Christiana Care Health System-Concord Health Center

🇺🇸

Chadds Ford, Pennsylvania, United States

Geisinger Medical Center

🇺🇸

Danville, Pennsylvania, United States

Grant Medical Center

🇺🇸

Columbus, Ohio, United States

UPMC-Shadyside Hospital

🇺🇸

Pittsburgh, Pennsylvania, United States

Delaware Radiation Oncology

🇺🇸

Delaware, Ohio, United States

Lewistown Hospital

🇺🇸

Lewistown, Pennsylvania, United States

UPMC-Coraopolis/Heritage Valley Radiation Oncology

🇺🇸

Moon, Pennsylvania, United States

State University of New York Downstate Medical Center

🇺🇸

Brooklyn, New York, United States

Oklahoma Cancer Specialists and Research Institute-Tulsa

🇺🇸

Tulsa, Oklahoma, United States

Mount Carmel Health Center West

🇺🇸

Columbus, Ohio, United States

UPMC-Saint Margaret

🇺🇸

Pittsburgh, Pennsylvania, United States

University of Pittsburgh Cancer Institute (UPCI)

🇺🇸

Pittsburgh, Pennsylvania, United States

Women and Infants Hospital

🇺🇸

Providence, Rhode Island, United States

OhioHealth Mansfield Hospital

🇺🇸

Mansfield, Ohio, United States

Knox Community Hospital

🇺🇸

Mount Vernon, Ohio, United States

Southern Ohio Medical Center

🇺🇸

Portsmouth, Ohio, United States

Licking Memorial Hospital

🇺🇸

Newark, Ohio, United States

UPMC Cancer Center at UPMC McKeesport

🇺🇸

McKeesport, Pennsylvania, United States

UPMC-Passavant Hospital

🇺🇸

Pittsburgh, Pennsylvania, United States

Geisinger Medical Center-Cancer Center Hazleton

🇺🇸

Hazleton, Pennsylvania, United States

Community Medical Center

🇺🇸

Scranton, Pennsylvania, United States

Franciscan Research Center-Northwest Medical Plaza

🇺🇸

Tacoma, Washington, United States

Harrison HealthPartners Hematology and Oncology-Poulsbo

🇺🇸

Poulsbo, Washington, United States

Geisinger Medical Group

🇺🇸

State College, Pennsylvania, United States

Prisma Health Cancer Institute - Easley

🇺🇸

Easley, South Carolina, United States

UPMC-Johnstown/John P. Murtha Regional Cancer Center

🇺🇸

Johnstown, Pennsylvania, United States

Geisinger Medical Oncology-Lewisburg

🇺🇸

Lewisburg, Pennsylvania, United States

UPMC Cancer Center at UPMC Northwest

🇺🇸

Seneca, Pennsylvania, United States

UPMC Uniontown Hospital Radiation Oncology

🇺🇸

Uniontown, Pennsylvania, United States

Geisinger Wyoming Valley/Henry Cancer Center

🇺🇸

Wilkes-Barre, Pennsylvania, United States

Geisinger Cancer Services-Pottsville

🇺🇸

Pottsville, Pennsylvania, United States

Northwest Medical Specialties PLLC

🇺🇸

Tacoma, Washington, United States

Prisma Health Cancer Institute - Faris

🇺🇸

Greenville, South Carolina, United States

Prisma Health Cancer Institute - Greer

🇺🇸

Greer, South Carolina, United States

UPMC Washington Hospital Radiation Oncology

🇺🇸

Washington, Pennsylvania, United States

University of Virginia Cancer Center

🇺🇸

Charlottesville, Virginia, United States

Harrison HealthPartners Hematology and Oncology-Bremerton

🇺🇸

Bremerton, Washington, United States

Saint Francis Hospital

🇺🇸

Federal Way, Washington, United States

Saint Clare Hospital

🇺🇸

Lakewood, Washington, United States

Fred Hutchinson Cancer Research Center

🇺🇸

Seattle, Washington, United States

Seattle Cancer Care Alliance

🇺🇸

Seattle, Washington, United States

University of Washington Medical Center

🇺🇸

Seattle, Washington, United States

Women's Cancer Center of Nevada

🇺🇸

Las Vegas, Nevada, United States

University of Kansas Hospital-Westwood Cancer Center

🇺🇸

Westwood, Kansas, United States

Cheyenne Regional Medical Center-West

🇺🇸

Cheyenne, Wyoming, United States

Billings Clinic-Cody

🇺🇸

Cody, Wyoming, United States

Welch Cancer Center

🇺🇸

Sheridan, Wyoming, United States

Abington Memorial Hospital

🇺🇸

Abington, Pennsylvania, United States

University of Rochester

🇺🇸

Rochester, New York, United States

Health Partners Inc

🇺🇸

Minneapolis, Minnesota, United States

Good Samaritan Hospital - Cincinnati

🇺🇸

Cincinnati, Ohio, United States

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

Bethesda North Hospital

🇺🇸

Cincinnati, Ohio, United States

TriHealth Cancer Institute-Westside

🇺🇸

Cincinnati, Ohio, United States

TriHealth Cancer Institute-Anderson

🇺🇸

Cincinnati, Ohio, United States

University of Oklahoma Health Sciences Center

🇺🇸

Oklahoma City, Oklahoma, United States

Vanderbilt Breast Center at One Hundred Oaks

🇺🇸

Nashville, Tennessee, United States

Mercy Hospital Oklahoma City

🇺🇸

Oklahoma City, Oklahoma, United States

Vanderbilt University/Ingram Cancer Center

🇺🇸

Nashville, Tennessee, United States

Freeman Health System

🇺🇸

Joplin, Missouri, United States

Denver Health Medical Center

🇺🇸

Denver, Colorado, United States

The Women's Imaging Center

🇺🇸

Denver, Colorado, United States

Rose Medical Center

🇺🇸

Denver, Colorado, United States

Colorado Blood Cancer Institute

🇺🇸

Denver, Colorado, United States

Presbyterian - Saint Lukes Medical Center - Health One

🇺🇸

Denver, Colorado, United States

Rocky Mountain Cancer Centers-Midtown

🇺🇸

Denver, Colorado, United States

John Muir Medical Center-Walnut Creek

🇺🇸

Walnut Creek, California, United States

Rocky Mountain Cancer Centers-Penrose

🇺🇸

Colorado Springs, Colorado, United States

National Jewish Health-Main Campus

🇺🇸

Denver, Colorado, United States

Porter Adventist Hospital

🇺🇸

Denver, Colorado, United States

SCL Health Saint Joseph Hospital

🇺🇸

Denver, Colorado, United States

Rocky Mountain Cancer Centers-Rose

🇺🇸

Denver, Colorado, United States

Mercy Medical Center

🇺🇸

Durango, Colorado, United States

Mountain Blue Cancer Care Center - Swedish

🇺🇸

Englewood, Colorado, United States

Mountain Blue Cancer Care Center

🇺🇸

Golden, Colorado, United States

Swedish Medical Center

🇺🇸

Englewood, Colorado, United States

National Jewish Health-Western Hematology Oncology

🇺🇸

Golden, Colorado, United States

North Colorado Medical Center

🇺🇸

Greeley, Colorado, United States

Rocky Mountain Cancer Centers-Lakewood

🇺🇸

Lakewood, Colorado, United States

Saint Anthony Hospital

🇺🇸

Lakewood, Colorado, United States

Rocky Mountain Cancer Centers-Littleton

🇺🇸

Littleton, Colorado, United States

Littleton Adventist Hospital

🇺🇸

Littleton, Colorado, United States

Fairview Lakes Medical Center

🇺🇸

Wyoming, Minnesota, United States

Rocky Mountain Cancer Centers-Sky Ridge

🇺🇸

Lone Tree, Colorado, United States

Longmont United Hospital

🇺🇸

Longmont, Colorado, United States

Rocky Mountain Cancer Centers-Longmont

🇺🇸

Longmont, Colorado, United States

McKee Medical Center

🇺🇸

Loveland, Colorado, United States

Parker Adventist Hospital

🇺🇸

Parker, Colorado, United States

Saint Louis Cancer and Breast Institute-Ballwin

🇺🇸

Ballwin, Missouri, United States

Rocky Mountain Cancer Centers-Parker

🇺🇸

Parker, Colorado, United States

Saint Mary Corwin Medical Center

🇺🇸

Pueblo, Colorado, United States

Rocky Mountain Cancer Centers - Pueblo

🇺🇸

Pueblo, Colorado, United States

National Jewish Health-Northern Hematology Oncology

🇺🇸

Thornton, Colorado, United States

SCL Health Lutheran Medical Center

🇺🇸

Wheat Ridge, Colorado, United States

Beebe Medical Center

🇺🇸

Lewes, Delaware, United States

Helen F Graham Cancer Center

🇺🇸

Newark, Delaware, United States

Delaware Clinical and Laboratory Physicians PA

🇺🇸

Newark, Delaware, United States

Medical Oncology Hematology Consultants PA

🇺🇸

Newark, Delaware, United States

Christiana Care Health System-Christiana Hospital

🇺🇸

Newark, Delaware, United States

TidalHealth Nanticoke / Allen Cancer Center

🇺🇸

Seaford, Delaware, United States

Christiana Care Health System-Wilmington Hospital

🇺🇸

Wilmington, Delaware, United States

Sacred Heart Hospital

🇺🇸

Pensacola, Florida, United States

Kootenai Cancer Center

🇺🇸

Post Falls, Idaho, United States

Kootenai Medical Center

🇺🇸

Coeur d'Alene, Idaho, United States

Kootenai Cancer Clinic

🇺🇸

Sandpoint, Idaho, United States

Northwestern University

🇺🇸

Chicago, Illinois, United States

University of Chicago Comprehensive Cancer Center

🇺🇸

Chicago, Illinois, United States

Northwestern Medicine Lake Forest Hospital

🇺🇸

Lake Forest, Illinois, United States

Good Samaritan Regional Health Center

🇺🇸

Mount Vernon, Illinois, United States

UC Comprehensive Cancer Center at Silver Cross

🇺🇸

New Lenox, Illinois, United States

University of Chicago Medicine-Orland Park

🇺🇸

Orland Park, Illinois, United States

Parkview Hospital Randallia

🇺🇸

Fort Wayne, Indiana, United States

Medical Oncology and Hematology Associates-West Des Moines

🇺🇸

Clive, Iowa, United States

Mercy Cancer Center-West Lakes

🇺🇸

Clive, Iowa, United States

Alegent Health Mercy Hospital

🇺🇸

Council Bluffs, Iowa, United States

Greater Regional Medical Center

🇺🇸

Creston, Iowa, United States

Medical Oncology and Hematology Associates-Laurel

🇺🇸

Des Moines, Iowa, United States

Mercy Medical Center - Des Moines

🇺🇸

Des Moines, Iowa, United States

University of Iowa/Holden Comprehensive Cancer Center

🇺🇸

Iowa City, Iowa, United States

Mercy Medical Center-West Lakes

🇺🇸

West Des Moines, Iowa, United States

University of Kansas Cancer Center

🇺🇸

Kansas City, Kansas, United States

Flaget Memorial Hospital

🇺🇸

Bardstown, Kentucky, United States

Saint Joseph Radiation Oncology Resource Center

🇺🇸

Lexington, Kentucky, United States

Commonwealth Cancer Center-Corbin

🇺🇸

Corbin, Kentucky, United States

Saint Joseph Hospital East

🇺🇸

Lexington, Kentucky, United States

Central Care Cancer Center - Bolivar

🇺🇸

Bolivar, Missouri, United States

Saint Joseph London

🇺🇸

London, Kentucky, United States

Jewish Hospital

🇺🇸

Louisville, Kentucky, United States

Saints Mary and Elizabeth Hospital

🇺🇸

Louisville, Kentucky, United States

Jewish Hospital Medical Center Northeast

🇺🇸

Louisville, Kentucky, United States

Jewish Hospital Medical Center South

🇺🇸

Shepherdsville, Kentucky, United States

Louisiana State University Health Science Center

🇺🇸

New Orleans, Louisiana, United States

Ochsner Medical Center Jefferson

🇺🇸

New Orleans, Louisiana, United States

Willis-Knighton Medical and Cancer Center

🇺🇸

Shreveport, Louisiana, United States

Greater Baltimore Medical Center

🇺🇸

Baltimore, Maryland, United States

Mercy Hospital

🇺🇸

Coon Rapids, Minnesota, United States

Fairview Ridges Hospital

🇺🇸

Burnsville, Minnesota, United States

Unity Hospital

🇺🇸

Fridley, Minnesota, United States

Fairview Southdale Hospital

🇺🇸

Edina, Minnesota, United States

Fairview Clinics and Surgery Center Maple Grove

🇺🇸

Maple Grove, Minnesota, United States

Minnesota Oncology Hematology PA-Maplewood

🇺🇸

Maplewood, Minnesota, United States

Saint John's Hospital - Healtheast

🇺🇸

Maplewood, Minnesota, United States

Abbott-Northwestern Hospital

🇺🇸

Minneapolis, Minnesota, United States

Hennepin County Medical Center

🇺🇸

Minneapolis, Minnesota, United States

New Ulm Medical Center

🇺🇸

New Ulm, Minnesota, United States

North Memorial Medical Health Center

🇺🇸

Robbinsdale, Minnesota, United States

Regions Hospital

🇺🇸

Saint Paul, Minnesota, United States

United Hospital

🇺🇸

Saint Paul, Minnesota, United States

Saint Francis Regional Medical Center

🇺🇸

Shakopee, Minnesota, United States

Lakeview Hospital

🇺🇸

Stillwater, Minnesota, United States

Ridgeview Medical Center

🇺🇸

Waconia, Minnesota, United States

Minnesota Oncology Hematology PA-Woodbury

🇺🇸

Woodbury, Minnesota, United States

Cox Cancer Center Branson

🇺🇸

Branson, Missouri, United States

Mercy Hospital Joplin

🇺🇸

Joplin, Missouri, United States

Delbert Day Cancer Institute at PCRMC

🇺🇸

Rolla, Missouri, United States

Mercy Clinic-Rolla-Cancer and Hematology

🇺🇸

Rolla, Missouri, United States

Heartland Regional Medical Center

🇺🇸

Saint Joseph, Missouri, United States

Saint Louis Cancer and Breast Institute-South City

🇺🇸

Saint Louis, Missouri, United States

Mercy Hospital Saint Louis

🇺🇸

Saint Louis, Missouri, United States

CoxHealth South Hospital

🇺🇸

Springfield, Missouri, United States

Mercy Hospital Washington

🇺🇸

Washington, Missouri, United States

Community Hospital of Anaconda

🇺🇸

Anaconda, Montana, United States

Benefis Healthcare- Sletten Cancer Institute

🇺🇸

Great Falls, Montana, United States

Community Medical Hospital

🇺🇸

Missoula, Montana, United States

Saint Elizabeth Regional Medical Center

🇺🇸

Lincoln, Nebraska, United States

CHI Health Good Samaritan

🇺🇸

Kearney, Nebraska, United States

Midlands Community Hospital

🇺🇸

Papillion, Nebraska, United States

Mercy Hospital Springfield

🇺🇸

Springfield, Missouri, United States

Park Nicollet Clinic - Saint Louis Park

🇺🇸

Saint Louis Park, Minnesota, United States

Rice Memorial Hospital

🇺🇸

Willmar, Minnesota, United States

Rocky Mountain Cancer Centers-Thornton

🇺🇸

Thornton, Colorado, United States

Rocky Mountain Cancer Centers-Aurora

🇺🇸

Aurora, Colorado, United States

University of Colorado Hospital

🇺🇸

Aurora, Colorado, United States

Alegent Health Lakeside Hospital

🇺🇸

Omaha, Nebraska, United States

Creighton University Medical Center

🇺🇸

Omaha, Nebraska, United States

Alegent Health Immanuel Medical Center

🇺🇸

Omaha, Nebraska, United States

Wake Forest University Health Sciences

🇺🇸

Winston-Salem, North Carolina, United States

Hematology and Oncology Consultants PC

🇺🇸

Omaha, Nebraska, United States

Alegent Health Bergan Mercy Medical Center

🇺🇸

Omaha, Nebraska, United States

OhioHealth Marion General Hospital

🇺🇸

Marion, Ohio, United States

Saint Ann's Hospital

🇺🇸

Westerville, Ohio, United States

UPMC-Presbyterian Hospital

🇺🇸

Pittsburgh, Pennsylvania, United States

Cancer Center of Western Wisconsin

🇺🇸

New Richmond, Wisconsin, United States

Great Falls Clinic

🇺🇸

Great Falls, Montana, United States

CHI Health Saint Francis

🇺🇸

Grand Island, Nebraska, United States

Prisma Health Cancer Institute - Laurens

🇺🇸

Clinton, South Carolina, United States

Prisma Health Cancer Institute - Spartanburg

🇺🇸

Spartanburg, South Carolina, United States

Memorial Hospital

🇺🇸

Chattanooga, Tennessee, United States

Prisma Health Cancer Institute - Butternut

🇺🇸

Greenville, South Carolina, United States

Prisma Health Greenville Memorial Hospital

🇺🇸

Greenville, South Carolina, United States

Prisma Health Cancer Institute - Eastside

🇺🇸

Greenville, South Carolina, United States

Pulmonary Medicine Center of Chattanooga-Hixson

🇺🇸

Hixson, Tennessee, United States

Memorial GYN Plus

🇺🇸

Ooltewah, Tennessee, United States

CHI Saint Vincent Cancer Center Hot Springs

🇺🇸

Hot Springs, Arkansas, United States

Bozeman Deaconess Hospital

🇺🇸

Bozeman, Montana, United States

Beebe Health Campus

🇺🇸

Rehoboth Beach, Delaware, United States

Saint Peter's Community Hospital

🇺🇸

Helena, Montana, United States

Heartland Hematology and Oncology

🇺🇸

Kearney, Nebraska, United States

Geisinger Medical Oncology-Selinsgrove

🇺🇸

Selinsgrove, Pennsylvania, United States

Prisma Health Cancer Institute - Seneca

🇺🇸

Seneca, South Carolina, United States

Vanderbilt-Ingram Cancer Center Cool Springs

🇺🇸

Franklin, Tennessee, United States

Saint Joseph Regional Cancer Center

🇺🇸

Bryan, Texas, United States

Harrison Medical Center

🇺🇸

Bremerton, Washington, United States

Highline Medical Center-Main Campus

🇺🇸

Burien, Washington, United States

Saint Elizabeth Hospital

🇺🇸

Enumclaw, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath